$0.04
Price
$9M
Market Cap
—
P/E Ratio
—
Forward P/E
$-0.66
EPS (TTM)
—
Dividend Yield
$26M
Cash
$74M
Total Debt
265M
Shares Out
$0.01
$0.62
52-Week Range
Institutional Ownership of Adaptimmune Therapeutics PLC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Adaptimmune Therapeutics PLC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for Adaptimmune Therapeutics PLC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.